Christopher Berger, MD
Christopher Berger, MD, MSIMT is a clinical fellow in the UCSF Division of Pulmonary Critical Care Medicine, clinically based at Zuckerberg San Francisco General Hospital. His research focuses on improving tuberculosis screening, diagnosis, and treatment programs globally through the use of implementation science and human-centered design principles. He works with Dr. Adithya Cattamanchi on projects in the Philippines to improve the diagnostic and clinical tools used in MDR and XDR TB and in Uganda designing improved versions of the globally utilized “Directly Observed Therapy” toolkit. Christopher completed his undergraduate degree in international health at the University of Pittsburgh where he went on complete his MD. He received his masters in tropical medicine and international health at the Universitat Autonoma de Barcelona in Barcelona, Spain. He completed his internal medicine residency at UCSF where he is currently finishing his pulmonary/critical care fellowship.
- Protocol for the 3HP Options Trial: a hybrid type 3 implementation-effectiveness randomized trial of delivery strategies for short-course tuberculosis preventive therapy among people living with HIV in Uganda.
- Summary for Clinicians: 2019 Clinical Practice Guideline Summary for the Treatment of Drug-Resistant Tuberculosis.
- Implementation science to improve the quality of tuberculosis diagnostic services in Uganda.